Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: flickerful who wrote (4709)	8/3/1998 3:16:00 AM
From: hilm	Read Replies (2) \| Respond to of 9523

flickerful<<just happened to catch (post x-files...what can i say) a piece on the viagra alternative... alleged to be 60% effective, basomax (sp?)>> The drug is vasomax. Discussed previously I believe. In short it will not be a challenge to viagra. The effective rate is closer to 40%, not much higher than placebo. Not impressive in the least in clinical trials. The only challenge to viagra will come from ICOS' drug when it comes out in 2 to 3 years. hilm